NewInsight: The AI sell-off compared to well-known stock market crashes

IQVIA IQV

IQVIA is the 252nd largest S&P 500 company by market cap, worth $44.8 billion. Its board has 10 directors, 8 of them independent. 9 other officers are on file. At 30 Jun 2026, Vanguard was its largest institutional holder, with 12.1% of the company.

Chair and CEO
Ari Bousbib
Sector
Health CareLife Sciences Tools & Services
Headquarters
Durham, North Carolina
Founded
1982
Market cap
$44.8B
252nd largest, 6 Nov 2026 close
Revenue
$16.3B
Fiscal year 2025
Price to sales
2.8
Market cap over revenue
Employees
93,000
10-K, 31 Dec 2025
Per employee
$482K
Market cap over employees
Connections
3
Companies sharing people

Financials

Latest quarter

Third Quarter 2026 figures from IQVIA's earnings release.

Filed 27 Oct 2026

Revenue
$4.4B
Up 8.0% year over year
Net income
$350M
Up 5.7% year over year
Diluted EPS
$2.10
Up 8.8% year over year

Reported figures

Figures from the release, against the same period a year earlier.

FigureValueYear earlierChange
Revenue$4.4B$4.1B+8.0%
GAAP Net Income$350M$331M+5.7%
Adjusted EBITDA$1.0B$949M+8.7%
GAAP Diluted Earnings per Share$2.10$1.93+8.8%
Adjusted Diluted Earnings per Share$3.34$3.00+11%
Adjusted Net Income$557M$515M+8.2%
Operating Cash Flow$825M$908M-9.1%
Free Cash Flow$667M$772M-14%

Financial history

Twelve months to 30 Sep 2026, from IQVIA's quarterly filings.

Quarters since Dec 2021

Revenue
$17.3B
Up 8.8% on the year before
Net income
$1.4B
8.1% of revenue
Free cash flow
$2.1B
Operating cash flow less capital spending
P/E
32.1
Market cap over net income

Quarterly results

Each quarter's revenue, net income and free cash flow.

Dec 2021 to Sep 2026

$0$2B$4B$6B202120222023202420252026$4.4B

Per employee

Twelve months to 30 Sep 2026, over 93,000 employees in IQVIA's latest 10-K.

Revenue
$186K
Operating profit
$24K
12.8% of revenue
Net income
$15K
8.1% of revenue

IQVIA's market cap since May 2013

Marked weeks are changes in the share count, such as a merger, not market moves.

Weekly, up to 6 Nov 2026

Show equal percentage changes as equal steps.
2014201620182020202220242026$44.8B

Board and leadership

Board and officers

3 people here also hold roles at other S&P 500 companies.

Board from the proxy filed 27 Feb 2026; officers filed up to 30 Sep 2026

NameTitleSinceIndependentCommitteesAge
Directors (10)
Ari BousbibChair; OfficerNot independent · since 2016Also at The Home DepotChair; Officer2016No64
Carol BurtDirectorIndependent · since 2019 · Audit, Leadership Development and Compensation (chair)Principal, Burt-Hilliard Investments; Senior Advisor, Consonance Capital PartnersAlso at ResMedDirector2019YesAudit, Leadership Development and Compensation (chair)68
John G. DanhaklDirectorIndependent · since 2016 · Leadership Development and Compensation, Nominating and GovernanceManaging Partner, Leonard Green & Partners, L.P.Other boards: Life Time Group Holdings and Mister Car WashDirector2016YesLeadership Development and Compensation, Nominating and Governance69
Jim FasanoDirectorIndependent · since 2016 · Audit (chair), Leadership Development and CompensationRetired Managing Director, CPP Investment Board; Adjunct Professor, University of Chicago Booth School of BusinessDirector2016YesAudit (chair), Leadership Development and Compensation56
Colleen A. GogginsDirectorIndependent · since 2017 · Audit, Nominating and Governance (chair)Retired Member of Executive Committee and Worldwide Chair of Consumer Group, Johnson & JohnsonOther boards: Bayer AGDirector2017YesAudit, Nominating and Governance (chair)71
William G. Kaelin Jr.DirectorIndependent · since 2025Senior Physician-Scientist, Brigham and Women's Hospital; Sidney Farber Professor of Medicine, Dana-Farber Cancer Institute and Harvard Medical SchoolAlso at Eli LillyDirector2025Yes68
John M. LeonardLead Independent DirectorIndependent · since 2015 · Audit, Nominating and GovernancePresident and Chief Executive Officer, Intellia Therapeutics, Inc.Other boards: Intellia TherapeuticsLead Independent Director2015YesAudit, Nominating and Governance68
Leslie Wims MorrisDirectorIndependent · since 2022 · Nominating and GovernanceChief Executive Officer, Chase Auto, JP Morgan ChaseDirector2022YesNominating and Governance55
Sheila A. StampsDirectorIndependent · since 2022 · AuditRetired Managing Director, Bank of AmericaOther boards: MFA FinancialDirector2022YesAudit68
Morris Leslie WimsDirectorDirector
Officers (9)
Ronald E. BruehlmanEVP & Chief Financial OfficerLast filed 10 Feb 2026EVP & Chief Financial Officer
James G. BerkshireEVP, Global Infrastructure and OperationsLast filed 4 Sep 2026EVP, Global Infrastructure and Operations
Keriann CherofskyOfficerLast filed 31 Jul 2026Officer
Michael J. FedockSVP, Fp&ALast filed 17 Feb 2026SVP, Fp&A
Alistair GrenfellPresident, Commercial SolutionsLast filed 11 Feb 2026President, Commercial Solutions
Bernd HaasEVP, AI and Technology SolutionsLast filed 17 Feb 2026EVP, AI and Technology Solutions
Bhavik PatelOfficerLast filed 4 Aug 2026Officer
Eric SherbetOfficerLast filed 31 Jul 2026Officer
W. Richard StaubOfficerLast filed 4 Aug 2026Officer

Companies that share people with IQVIA

Each person's title here, then at the other company.

  • The Home Depot HD
    • Ari Bousbib: Officer here, Director there
  • Eli Lilly LLY
    • William G. Kaelin Jr.: Director here, Director there
  • ResMed RMD
    • Carol Burt: Director here, Director there

Owners and trading

Largest institutional holders

Each fund group's share of IQVIA. Where a company has several share classes, the share is of its total value.

13F filings for the quarter to 30 Jun 2026

These five hold 36.3% of IQVIA.

Insider trades

Open-market buys and sales by directors and officers. Grants, option exercises and shares withheld for tax are left out.

Trades from 6 Nov 2025 to 6 Nov 2026

Directors and officers sold $38.0 million of stock in 7 sales and made no open-market purchases in the 12 months to 6 Nov 2026.

DatePersonTitleTypeSharesValue
2 Sep 2026SaleJames G. BerkshireEVP, Global Infrastructure and OperationsEVP, Global Infrastructure and OperationsSale2,668$697K
3 Aug 2026SaleW. Richard StaubOfficerOfficerSale5,500$1.3M
31 Jul 2026SaleBhavik PatelOfficerOfficerSale1,855$436K
29 Jul 2026SaleAri BousbibOfficerOfficerSale106,279$26M
29 Jul 2026SaleEric SherbetOfficerOfficerSale5,000$1.2M
29 Jul 2026SaleKeriann CherofskyOfficerOfficerSale558$137K
18 Dec 2025SaleAri BousbibOfficerOfficerSale36,564$8.1M

Trades by members of Congress and officials

Trades members of Congress and senior executive branch officials disclosed, including their families'. Amounts are filed as ranges.

Trades from 27 Oct 2023 to 27 Oct 2026

7 people disclosed 17 purchases and 21 sales of IQVIA stock since October 2023.

DateMember or officialTypeAmount
14 Sep 2026Kevin Hern (House, R-OK)House, R-OK · SoldSale$15,001 to $50,000$15K to $50K
8 Sep 2026Kevin Hern (House, R-OK)House, R-OK · SoldSale$1,001 to $15,000$1K to $15K
3 Sep 2026Kevin Hern (House, R-OK)House, R-OK · SoldSale$1,001 to $15,000$1K to $15K
23 Jun 2026Donald J Trump (President)President · SoldSale$1,001 to $15,000$1K to $15K
22 May 2026Donald J Trump (President)President · SoldSale$15,001 to $50,000$15K to $50K
21 May 2026Donald J Trump (President)President · BoughtPurchase$1,001 to $15,000$1K to $15K
18 May 2026Markwayne Mullin (Secretary)Secretary · SoldSale$50,001 to $100,000$50K to $100K
27 Apr 2026Donald J Trump (President)President · SoldSale$15,001 to $50,000$15K to $50K
13 Apr 2026Rohit Khanna (House, D-CA)House, D-CA · SoldSale$1,001 to $15,000$1K to $15K
10 Apr 2026Donald J Trump (President)President · SoldSale$1,001 to $15,000$1K to $15K

Showing 10 of 38 trades

Workforce and hiring

Workforce

Headcount at 31 Dec 2025

Employees
93,000

Employees, last 10 fiscal years

Up 33% in five years, from 70,000 in 2020 to 93,000 in 2025.

With approximately 93,000 employees in over 100 countries, including experts in healthcare, life sciences, data science, technology and operational excellence, we are dedicated to accelerating the development and commercialization of innovative medical treatments to help improve patient outcomes and population health worldwide.
IQVIA Form 10-K

Open roles

Jobs listed on IQVIA's careers site, each counted once.

Daily, up to 3 Nov 2026

Open roles
1,898
On 3 Nov 2026
Change
-47
Down 2.4% since 27 Oct 2026
Top function
Sales & Marketing
25% of open roles
Remote
8%
59% do not say

Open roles in detail

27 Oct 2026 to 3 Nov 2026

27 Oct3 Nov1,898

Timeline

Leadership changes, layoffs and insider sales

7 Nov 2024 to 7 Nov 2026; insider sales from 6 Nov 2025

1 departure and 2 appointments of directors and officers and 4 large insider sales in the last two years.

Left the company or board 1Appointed 2WARN layoff notices 0Large insider sales 4Jan 2025AprJulOctJan 2026AprJulOct

Insider sales of $1 million or more, and the largest tenth of IQVIA's insider sales.

Events, newest first

Not on file: no WARN layoff notices under its own name or a listed subsidiary's since November 2023.